|Nome||Titolo||Retribuzione||Esercitate||Anno di nascita|
|Mr. Dongchen Cai||Exec. Chairman & CEO||13,8M||N/D||1954|
|Mr. Cuilong Zhang||Vice-Chairman, Rotating CEO & Pres of Oncology Drug Bus. Division||4,33M||N/D||1969|
|Mr. Kin Man Chak||Exec. Director||5,27M||N/D||1966|
|Mr. Weidong Pan||Exec. Director||4,39M||N/D||1970|
|Mr. Huaiyu Wang||Exec. Director||4,21M||N/D||1963|
CSPC Pharmaceutical Group Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China, other Asian regions, the Americas, Europe, and internationally. The company operates through Finished Drugs, Vitamin C, Antibiotics, and Caffeine and Others segments. It offers NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Xuanning for hypertension; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; Ailineng for nerve glioma and brain metastases, and adjuvant treatment of malignant pleural and peritoneal effusion; Nuolining for chronic myelocytic and acute lymphoblastic leukemia; and Keaili for breast cancer. The company also provides generic drugs, including Ouyi for anti-inflammatory, Gubang to treat osteoporosis, and Weihong for various infections, as well as Guoweikang, a vitamin C supplement tablets; traditional Chinese medicine; and antibiotics comprising Amoxicillin and Ampicillin capsules, Ceftriaxone and Cefazolin sodium injections, and Meropenum injections. In addition, the company offers antibiotics, vitamin C, and caffeine APIs; and researches and develops various products with focus on the therapeutic areas of cardio-cerebrovascular diseases, metabolic diseases, oncology, psychiatry, and neurology, as well as anti-infection. Further, it provides storage, sourcing, and distribution services; medical services; and sewage products. Additionally, the company engages in the property holding; and sale of pharmaceutical equipment. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. The company was founded in 1997 and is headquartered in Shijiazhuang, the People's Republic of China.
L'ISS Governance QualityScore di CSPC Pharmaceutical Group Limited al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.